According to the latest study published by MarkNtel Advisors, the Global Rapid Food Testing Market is projected to grow at a ...

Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver ...

Have you assessed how the international operations of Bio-Rad Laboratories (BIO) performed in the quarter ended December 2025? For this maker of instruments used in biomedical research, possessing an ...

Bio-Rad develops products and solutions for the life sciences research and clinical diagnostic markets and enjoys niche market leadership in diagnostic quality controls, antigens, and digital ...

Edward Chung: Today, we will review the fourth quarter and full year 2025 financial results and provide an update on key business trends for Bio-Rad Laboratories, Inc. With me on the call today are ...

Jonathan DiVincenzo, President & COO, reported that "revenue was consistent with our outlook and operating margin exceeded consensus, a testament to the discipline and agility of our teams in what ...

BIO surged 45% after its Upbit listing, reigniting interest in the DeSci sector. The token broke above a descending triangle with strong MFI and AO readings. Sustained momentum could push BIO toward ...

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, and Gencurix, Inc., a leading Korean developer of oncology testing solutions, today announced ...

Bio Protocol secured $6.9 million in funding from Maelstrom Fund, Animoca Brands and other investors to advance science using AI and crypto. Decentralized science (DeSci) platform Bio Protocol secured ...